This trial is active, not recruiting.

Conditions schizophrenia, chronic psychiatric disorder
Treatment data collection
Sponsor CHU de Reims
Start date January 2010
End date July 2018
Trial size 685 participants
Trial identifier NCT02884739, PN08001


As in the general population, there is a gradual and steady increase in life expectancy of patients with schizophrenia. But this increase is at a smaller scale, with a rate of premature death that is still 2 to 3 times higher than that found in the general population. This excessive early mortality is explained by an overrepresentation of suicide deaths, but also a higher prevalence of somatic diseases, mainly cardiovascular. But today there are only very few epidemiological data on the mortality of patients with schizophrenia, including those aged over 60 years. What are the sociodemographic and clinical characteristics (psychiatric and somatic) of these schizophrenic elderly patients? Do they benefit from a somatic follow-up adequate and systematic? What are their levels of social independence and of quality of life? the answers these questions and the description of the offer of geriatric care and of psychiatric care currently provided by different sectors of psychiatry in France is an indispensable prerequisite for any project to improve the quality of life, state of health and mortality of older patients with schizophrenia.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
data collection
data collection

Primary Outcomes

time frame: 5 years

Eligibility Criteria

Male or female participants at least 60 years old.

Inclusion Criteria: - Men or women aged than 60 years with a diagnosis of schizophrenia, according to the DSM-IV criteria - Men or women aged than 60 years with chronic psychiatric disorder other than schizophrenia - Patients consenting to participate to the study - Patients enrolled in the national healthcare insurance program Exclusion Criteria: -Disease affecting the central nervous system

Additional Information

Official title The Mortality and Its Associated Factors in Schizophrenia Patients Older Than 60 Years
Description Evaluate prospectively over 5 years, the rates and causes of mortality in a cohort of schizophrenic patients older than 60 years, followed by adult psychiatry sectors, compared to those patients matched for sex and age and monitored by the same sectors for a chronic psychiatric disorder other than schizophrenia
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by CHU de Reims.